Los Angeles-based Abraxis BioScience announced this morning that it has named Lex H.T. Van der Ploeg, Ph.D., as Senior Vice President of Integrative Medicine and Translational Science at its new spinoff, Abraxis Health. Van der Ploeg joins the firm from Merck Research Laboratories, where he was Vice President, Basic Research and Site Head. Abraxis said that Dr. Van der Ploeg has more than 25 years of experience in enzymology, biochemistry and genetics. Abraxis BioScience said this week that it is spinning off Abraxis Health to focus on personalized medicine and biomarkers.
Top NewsWednesday, January 21, 2009
Abraxis BioScience Names VP